Khaykin P - Search Results

1

Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection.

Dietz J, Lutz T, Knecht G, Gute P, Berkowski C, Lange CM, Khaykin P, Stephan C, Brodt HR, Herrmann E, Zeuzem S, Sarrazin C. Dietz J, et al. Among authors: khaykin p. Virology. 2015 Nov;485:213-22. doi: 10.1016/j.virol.2015.06.030. Epub 2015 Aug 25. Virology. 2015. PMID: 26295281 Free article.

2

Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.

von Hentig N, Nisius G, Lennemann T, Khaykin P, Stephan C, Babacan E, Staszewski S, Kurowski M, Harder S, Haberl A. von Hentig N, et al. Among authors: khaykin p. Antivir Ther. 2008;13(8):1039-46. Antivir Ther. 2008. PMID: 19195329

3

Quadruple nucleos(t)ide reverse transcriptase inhibitors-only regimen of tenofovir plus zidovudine/lamivudine/abacavir in heavily pre-treated HIV-1 infected patients: salvage therapy or backbone only?

Stephan C, Dauer B, Khaykin P, Stuermer M, Gute P, Klauke S, Staszewski S. Stephan C, et al. Among authors: khaykin p. Curr HIV Res. 2009 May;7(3):320-6. doi: 10.2174/157016209788348010. Curr HIV Res. 2009. PMID: 19442129

4

Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting.

Haberl A, Moesch M, Nisius G, Stephan C, Bickel M, Khaykin P, Kurowski M, Brodt R, von Hentig N. Haberl A, et al. Among authors: khaykin p. Eur J Clin Pharmacol. 2010 Apr;66(4):375-81. doi: 10.1007/s00228-009-0767-8. Epub 2009 Dec 24. Eur J Clin Pharmacol. 2010. PMID: 20033681

5

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.

Antiretroviral Therapy Cohort Collaboration. Antiretroviral Therapy Cohort Collaboration. Clin Infect Dis. 2010 May 15;50(10):1387-96. doi: 10.1086/652283. Clin Infect Dis. 2010. PMID: 20380565 Free PMC article.

6

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.

Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Von Hentig N, Herrmann E, Doerr HW, Brodt HR, Allwinn R. Bickel M, et al. Among authors: khaykin p. AIDS. 2010 Jun 1;24(9):F31-5. doi: 10.1097/QAD.0b013e3283398da1. AIDS. 2010. PMID: 20559034

7

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients; Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, et al. Among authors: khaykin p. Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15. Lancet. 2010. PMID: 20638118 Free PMC article.

8

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

Bickel M, von Hentig N, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Herrmann E, Doerr HW, Brodt HR, Allwinn R. Bickel M, et al. Among authors: khaykin p. Clin Infect Dis. 2011 Jan 1;52(1):122-7. doi: 10.1093/cid/ciq003. Clin Infect Dis. 2011. PMID: 21148530 Clinical Trial.

9

Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapy.

Stephan C, Bartha V, Herrmann E, von Hentig N, Khaykin P, Knecht G, Gute P, Brodt HR, Stürmer M, Berger A, Bickel M. Stephan C, et al. Among authors: khaykin p. Med Microbiol Immunol. 2013 Apr;202(2):117-24. doi: 10.1007/s00430-012-0276-8. Epub 2012 Sep 15. Med Microbiol Immunol. 2013. PMID: 22983722

10

Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment.

Khaykin P, Kotzerke P, Stephan C, Nisius G, Bickel M, Haberl A, Stürmer M, Kurowski M, Brodt R, von Hentig N. Khaykin P, et al. Ther Drug Monit. 2014 Apr;36(2):192-201. doi: 10.1097/FTD.0b013e3182a28c6a. Ther Drug Monit. 2014. PMID: 24632753 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters